Biomedical subjects

L Schweitz

Publications and source records attributed to L Schweitz.

5 recordsLinked to original sources

PubMed2001

Molecularly imprinted microparticles for capillary electrochromatography: studies on microparticle synthesis and electrolyte composition.

The use of molecularly imprinted polymer (MIP) microparticles in a partial filling application of capillary electrochromatography (CEC) has previously been shown successful for the enantiomer separation of propranolol. In this investigation, the influence of some important parameters in the preparation protocol, i.e., template to monomer ratio, type of cross-linker and functional monomers, and the effect of separation condition, i.e., organic modifier content, pH and the temperature of the column, on the electrochromatographic behavior of the MIP microparticles were studied. It was found that ethyleneglycol dimethacrylate (EDMA), having two reactive double bonds, was superior in terms CEC performance to trimethylpropane trimethacrylate (TRIM) and pentaerythritol tetraacrylate (PETEA) having three and four double bonds, respectively. The use of weak functional monomers, i.e., monomers lacking a strong interaction with the template, was shown to increase the separation efficiency. It was found that the template to functional monomer ratio had a pronounced influence on the MIP microparticle partial filling CEC performance as well as the size of the obtained microparticles. The use of a partial filling technique realizes the use of a new MIP phase in every new separation as well as the ability of altering the selectivity of the separation column and length of the MIP without the need for column switching.

Adrenergic beta-Antagonists↗

PubMed2001

Approaches to molecular imprinting based selectivity in capillary electrochromatography.

The work done during the past decade in order to adapt molecularly imprinted polymers (MIPs) to the capillary format and subsequently use these highly selective matrices for capillary electrochromatography (CEC) are reviewed in this article. MIPs are prepared utilizing a templated polymer synthesis where the template addresses the selectivity of the resulting polymer. These polymers possess binding characteristics that are comparable to the biological antibodies. Due to the polyclonality of the binding sites in the MIP, the separation result in severe peak broadening and tailing when performed in the isocratic mode. This was seen early in the development of MIPs as selective stationary phases in liquid chromatography (LC). As a mean of decreasing these problems, much effort was put into adapting the MIP to fit in CEC systems, that offers an efficiency that is superior to that in LC. Aiming to increase the efficiency of the MIP-CEC systems, different MIP formats have been developed that can be divided into three conceptually different categories, i.e., the monolithic, the microparticle and the coating. The strive for MIP formats that can be used in small bore capillaries has led to the development of MIP formats applicable to miniaturized systems approaching the chip format. Although prepared in order to perform MIP-CEC mediated separations, these formats can be used in a broad range of applications were the characteristics of the MIP, e.g. stability, selectivity and cost efficiency, could offer an interesting solution to cover the needs.

Chromatography, Micellar Electrokinetic Capillary↗

PubMed2000

Alternative methods providing enhanced sensitivity and selectivity in capillary electroseparation experiments.

The study of alternative and novel techniques for altering selectivity and enhancing sensitivity as well as injection and detection protocols are important in the ongoing development of capillary electroseparation protocols. Some recent research from our laboratory in these fields is presented and discussed in this review. To improve sensitivity an off-line sample enrichment technique utilising solvent evaporation in a levitated drop or an on-line solid-phase extraction protocol was used. The selectivity was tuned by the use of protein gels or molecularly imprinted polymer mediated capillary electrochromatography. Furthermore, a picolitre droplet injection method is described as well as a detection protocol based on laser-induced fluorescence imaging.

Electrophoresis, Capillary↗

PubMed2000

Molecularly imprinted microparticles for capillary electrochromatographic enantiomer separation of propranolol.

Molecularly imprinted microparticles imprinted against (S)-propranolol were synthesised and studied for use in capillary electrochromatographic separation of propranolol enantiomers. The imprinted microparticles were in the size range of 0.2-0.5 micron as determined by scanning electron microscopy. The microparticles were suspended, in high concentration, in the electrolyte and used to perform enantiomer separation by a partial filling technique.

Adrenergic beta-Antagonists↗

PubMed1997

Three approaches to enantiomer separation of beta-adrenergic antagonists by capillary electrochromatography.

Three different capillary electrochromatographic methods for the enantiomer separation of beta-adrenergic antagonists (acebutolol, alprenolol, atenolol, metoprolol, pindolol, prenalterol, and propranolol) were applied using different cyclodextrins (beta-cyclodextrin, carboxymethyl-beta-cyclodextrin and dimethyl-beta-cyclodextrin) added to the electrolyte, a cross-linked protein-gel (cellobiohydrolase I) and a molecularly imprinted ((R)-enantiomer of propranolol) superporous polymer as chiral selectors. Through use of these different separation strategies, all the beta-adrenergic antagonists studied could be resolved into their enantiomers, although the three methods were carried out without extensive optimization. The protein and molecularly imprinted phases gave the highest selectivities whereas employing cyclodextrins resulted in the highest separation efficiency. Proteins and cyclodextrins are primarily natural products, albeit the cyclodextrins can be derivatized. In contrast, the molecularly imprinted chiral stationary phase can be highly customized when produced.

Adrenergic beta-Antagonists↗